From: Allergic conditions and risk of hematological malignancies in adults: a cohort study
Leukemia | Leukemia, excluding | CLL | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Exposure | N e | N o | RR | 95% CI | N e | N o | RR | 95% CI | N e | N o | RR | 95% CI |
Asthma, hay fever or hives | 31 | 94 | 1.4 | (0.9–2.1) | 21 | 43 | 2.0 | (1.2–3.4) | 10 | 51 | 0.8 | (0.4–1.6) |
Hay fever | 21 | 105 | 1.1 | (0.7–1.8) | 14 | 50 | 1.5 | (0.8–2.8) | 7 | 55 | 0.7 | (0.3–1.6) |
Asthma | 7 | 126 | 1.6 | (0.8–3.5) | 3 | 64 | 1.3 | (0.4–4.2) | 4 | 62 | 1.9 | (0.7–5.3) |
Hives | 7 | 120 | 2.1 | (1.0–4.5) | 6 | 58 | 3.6 | (1.6–8.5) | 1 | 62 | 0.6 | (0.1–4.3) |
Eczema* | 8 | 115 | 0.9 | (0.5–1.9) | 3 | 59 | 0.7 | (0.2–2.2) | 5 | 56 | 1.2 | (0.5–3.1) |
Allergic conditions** | 30 | 87 | 1.1 | (0.8–1.7) | 18 | 42 | 1.4 | (0.8–2.4) | 12 | 45 | 0.9 | (0.5–1.7) |